Springer

SHERPA: Unknown

People

  1. Pandit-Taskar
    Pandit-Taskar
  2. Humm
    Humm
  3. O'Donoghue
    O'Donoghue
  4. Zanzonico
    Zanzonico
  5. Kramer
    Kramer
  6. Morris
    Morris
  7. Carrasquillo
    Carrasquillo
  8. Cheung
    Cheung
  9. Lewis
    Lewis
  10. Lyashchenko
    Lyashchenko

Groups

  1. Molecular Imaging and Therapy Service (49)
  2. Radiology, Department of (49)
  3. GSK Faculty (20)
  4. Medical Physics (18)
  5. Sloan Kettering Institute Postdocs (17)
  6. Department of Medicine (14)
  7. Molecular Pharmacology and Chemistry Program Faculty (14)
  8. Sloan Kettering Institute Faculty (14)
  9. Solid Tumor Oncology Division (13)
  10. Body Imaging Service (10)
Search Within
  1. "Neeta Pandit-Taskar"
Formats
  1. Journal Article (25)
  2. Book Section (10)
  3. Meeting Abstract (10)
  4. Guidelines (3)
  5. Review (1)
Groups
  1. Molecular Imaging and Therapy Service (49)
  2. Radiology, Department of (49)
  3. GSK Faculty (20)
  4. Medical Physics (18)
  5. Sloan Kettering Institute Postdocs (17)
  6. Department of Medicine (14)

More Groups

People
  1. Neeta Pandit-Taskar (49)
  2. Steven Larson (14)
  3. John Humm (9)
  4. Joseph O'Donoghue (9)
  5. Pat Zanzonico (8)
  6. Kim Kramer (7)

More People

Years
  1. 2024 (3)
  2. 2023 (5)
  3. 2022 (9)
  4. 2021 (2)
  5. 2020 (1)
  6. 2019 (3)

More Years

Publications
  1. European Journal of Nuclear Medicine and Molecular Imaging (21)
  2. Journal of Neuro-Oncology (5)
  3. Nuclear Oncology: From Pathophysiology to Clinical Applications. 2nd ed (4)
  4. Nuclear Oncology: From Pathophysiology to Clinical Applications. 3rd ed (4)
  5. EJNMMI Research (3)
  6. Current Oncology Reports (2)

More Publications

Results (49)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bone marrow dosimetry exploratory analysis from the phase 3 SIERRA trial of (131)I-apamistamab prior to HCT in relapsed/refractory acute myeloid leukemia
    Meeting Abstract

    Pandit-Taskar, N.; Natwa, M.; Chen, M.; Leung, E.; Spross, J.; Li, K.; Desai, A.; Brodin, P.; Wahl, R.
    European Journal of Nuclear Medicine and Molecular Imaging (2024)

    Fulltext@MSK | Save
  • Modeling-based assessment of exposure measurements after high-dose targeted (131)I-apamistamab: Results and analyses from the phase III SIERRA trial
    Meeting Abstract

    Pandit-Taskar, N.; Chen, L.; Serencsits, B.; Prasad, K.; Senglaub, T.; Zgaljardic, M.; Spross, J.; Desai, A.; Brodin, P.
    European Journal of Nuclear Medicine and Molecular Imaging (2024)

    Fulltext@MSK | Save
  • Feasibility of safe outpatient treatment in pediatric patients following intraventricular radioimmunotherapy with (131)I-omburtamab for leptomeningeal disease
    Journal Article

    Prasad, K.; Serencsits, B. E.; Chu, B. P.; Dauer, L. T.; Donzelli, M.; Basu, E.; Kramer, K.; Pandit-Taskar, N.
    EJNMMI Research (2024)

    Fulltext@MSK | Save
  • Determination of the treatment coverage of theragnostic (124)I-8H9 antibody to treat diffuse pontine glioma by convective enhance delivery
    Meeting Abstract

    Velo, A. F.; Larsen, A. G.; Humm, J.; Zanzonico, P.; Souweidane, M.; Pandit-Taskar, N.
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • Feasibility of high- dose targeted radiation with I131apamistamab in patients with relapsed/refractory AML: Dosimetry and radiation safety experience from the phase 3 SIERRA trial
    Meeting Abstract

    Pandit-Taskar, N.; Prasad, K.; Chen, L.; Senglaub, T.; Zgaljardic, M.; Brodin, P.; Serencsits, B.
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • (89)Zr-DFO-girentuximab PET/CT imaging for clear cell renal cell carcinoma - ZIRCON study results of diagnostic performance, including in very small lesions
    Meeting Abstract

    Martina, S.; Mulders, P.; Shuch, B. M.; Pantuck, A. J.; Morris, M. A.; Master, V.; Scott, A.; Van Praet, C.; Bailly, C.; Onal, B.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • Safety and dosimetry evaluation of personalized dose I131-apamistamab prior to HCT in the phase 3 SIERRA trial for patients with relapsed/refractory acute myeloid leukemia (R/R AML)
    Meeting Abstract

    Pandit-Taskar, N.; Natwa, M.; Chen, M.; Yap, W.; Wiseman, G.; Leung, E.; Desai, A.; Brodin, P.; Haeuber, E.; Nahar, A.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymoma
    Journal Article

    Tringale, K. R.; Wolden, S. L.; Karajannis, M.; Haque, S.; Pasquini, L.; Yildirim, O.; Rosenblum, M.; Benhamida, J. K.; Cheung, N. K.; Souweidane, M.; more...
    Journal of Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Diagnostic applications of nuclear medicine: Uterine cancers
    Book Section

    Pandit-Taskar, N.; Mahajan, S.; Ma, W.
    In Volterrani, D.; Erba, P. A.; Strauss, H. W.; Mariani, G.; Larson, S. M. (Eds.) Nuclear Oncology: From Pathophysiology to Clinical Applications. 3rd ed (2022)

    Fulltext@MSK | Save
  • Diagnostic applications of nuclear medicine: Vulvar cancer
    Book Section

    Mahajan, S.; Ma, W.; Pandit-Taskar, N.
    In Volterrani, D.; Erba, P. A.; Strauss, H. W.; Mariani, G.; Larson, S. M. (Eds.) Nuclear Oncology: From Pathophysiology to Clinical Applications. 3rd ed (2022)

    Fulltext@MSK | Save